Ms. Sue T. Patrick, M.A., L.L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 520 N Main St, Suite 202, Cheboygan, MI 49721 Phone: 231-627-9917 |
Mr. Patrick Michael Mcginn, MS, LLP Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 524 Mackinaw Ave, Cheboygan, MI 49721 Phone: 231-597-8024 |
News Archive
Patients with interstitial lung disease—a group of disorders causing progressive scarring of lung tissue—are often prescribed various medications that specifically target their disease and others that treat their symptoms.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
The charity, A Better LA, said it would sign up 50 low-income Californians for Obamacare plans, but insurers protested that such help could skew insurance pools toward sicker people, The Wall Street Journal reports.
An Indiana University-Purdue University Indianapolis researcher has been awarded $1.1 million to develop information-based tools to help primary care providers improve care for patients with chronic pain, a condition that affects 100 million Americans at a cost of $630 billion annually in health care costs and lost worker productivity.
A team of molecular biologists and computer scientists at Stony Brook University have used a novel method to weaken (attenuate) influenza virus by way of designing hundreds of mutations to its genetic code to create an effective vaccine. Reported online and in the July issue of Nature Biotechnology, the method may be a major step in developing more effective and safe vaccines against influenza, which claims 250,000 to 500,000 lives annually worldwide, partly because existing vaccines are not fully effective.
› Verified 8 days ago